Oxford-based Exscientia uses AI to accelerate delivery of new treatments; get €3.44M from Gates … AI & Surroundings

Oxford-based leading pharmatech company Exscientia deploys Artificial Intelligence to drive drug discovery. It is claimed to be a pioneer in using AI to design a novel molecule to enter the clinic. Now, this company has raised funding to identify new targets and leads for a slew of ailments such as malaria, tuberculosis, and non-hormonal contraception. […]